Provided by Tiger Fintech (Singapore) Pte. Ltd.

IO Biotech, Inc.

1.48
-0.0700-4.52%
Post-market: 1.45-0.0291-1.97%19:07 EDT
Volume:180.01K
Turnover:270.58K
Market Cap:97.50M
PE:-0.99
High:1.60
Open:1.56
Low:1.45
Close:1.55
Loading ...
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 06, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Sep 30, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
May 26, 2022

Major Issues Report

8-K - Current report
May 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals